We’re discovering cancer’s weaknesses so we can make more personalised treatments that help more people live longer lives with fewer side effects.
We were there at the start of radiotherapy, more than 120 years ago. Ever since then, we've been making this lifesaving and life-improving treatment more effective, and more futuristic.
We're funding a pioneering new trial to find more and better treatment options for people with brain tumours.
Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source.
Prostate cancer cells can be hard for a surgeon to spot, so we're using a fluorescent dye to light them up.
Our scientists led the development of chemotherapy and radiotherapy and improved the way surgery is used to tackle cancer.
Millions
We were a key player in the development of radiotherapy, which now benefits millions of people with cancer worldwide.
8 in 10
More than 8 in 10 people who receive cancer drugs in the UK receive a drug developed by or with us.
9 in 10
More than 9 in 10 children and young people who receive cancer drugs in the UK receive a drug developed by or with us.
Find out how you can support our life-saving work.
Every day, breakthroughs are saving lives. That’s the power of our science.
